RADX - Radiopharm Theranostics Ltd Company Long-Term Liabilities

Public company logo of radiopharmtheranostics.com (RADX)

The price trend for Radiopharm Theranostics (RADX) reflects the dynamics of a biotech firm developing isotopic agents for the detection and destruction of tumors. The business relies on the principles of theranostics, combining precise pathology imaging with targeted treatment. The current metric stands at 0.00, while Radiopharm Theranostics (RADX) remains in the clinical trial phase, sustaining operations through external investments due to the absence of stable operating cash flow.

radiopharmtheranostics.com (RADX) Company Long-Term Debt: for the period 12/06/2024 - 10/31/2026

Radiopharm Theranostics Limited (RADX) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price radiopharmtheranostics.com|RADX - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Radiopharm Theranostics|RADX - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Radiopharm Theranostics|RADX - Company Book Value|Market Value to Book Value radiopharmtheranostics.com|RADX - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Radiopharm Theranostics|RADX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Radiopharm Theranostics Ltd|RADX - Company Total Debt|Debts to Book Capitalization Radiopharm Theranostics|RADX - Company Long-Term Debt|Company Short-Term Loans and Borrowings Radiopharm Theranostics|Immediate Liquidity radiopharmtheranostics.com
- earnings and market multiples details:
RADX - Company Net Income
Fundamental company valuation:RADX (radiopharmtheranostics.com)
Brand item of Radiopharm Theranostics

Radiopharm Theranostics' development of innovative cancer therapies, supported by outsourced production and testing, is reflected in the company's long-term debt metrics. This metric aggregates obligations with maturities exceeding one year, allowing investors to differentiate strategic investment in R&D scaling from critical liquidity shortages, which directly determines the credit risk and ultimate market value of Radiopharm Theranostics (RADX).

Competitors of Radiopharm Theranostics (RADX)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Debt TuHURA Biosciences, Inc. (HURA)|TARA (protaratx.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debts FATE (Fate Therapeutics)|Company Long-Term Debts Aadi Bioscience, Inc. WHWK|TScan - Company Long-Term Debts|CSBR (Champions Oncology) - Company Long-Term Indebtedness|XBIT: Company Long-Term Debts|CVM - Long-Term Debt Volume|Company Long-Term Debt OS Therapies|Long-Term Debt Artiva ARTV|Company Long-Term Debt Adlai Nortye Ltd. (ANL)|VERU: Long-Term Liabilities|Company Long-Term Debts TPST (Tempest Therapeutics)|Company Long-Term Loans and Borrowings XLO|Enochian BioSciences - Company Long-Term Debts|MURA - Company Long-Term Debts|kairospharma.com (KAPA) - Company Long-Term Debt|OnKure Therapeutics - Company Long-Term Loans and Borrowings|Company Long-Term Debt CytoMed Therapeutics Ltd|Company Long-Term Liabilities Curis Corp (CRIS)|Company Long-Term Liabilities APLM (Apollomics, Inc.)|THAR (Tharimmune Inc) - Company Long-Term Loans and Borrowings|Advanced Biomed - Company Long-Term Liabilities|Amount of Long-Term Liabilities GNPX (Genprex Inc)|Calidi Bio - Company Long-Term Debts|Company Long-Term Loans and Borrowings SBFM (Sunshine Biopharma Inc.)|XBIO: Company Long-Term Debts|Long-Term Debt Salarius Pharmaceuticals Inc (SLRX)|Company Long-Term Debt Purple Biotech Corp|AONC: Company Long-Term Loans and Borrowings|Company Long-Term Debts BGNE|Company Long-Term Debts checkpointtx.com (CKPT)|Company Long-Term Debt Elevation Oncology, Inc. ELEV|ICAD: Company Long-Term Indebtedness|IKNA - Company Long-Term Debt|Long-Term Debt Notable Labs Corp|viracta.com (VIRX) - Company Long-Term Debt|MOR - Long-Term Debt Volume|Company Long-Term Liabilities NAYA|AAPGV (Ascentage Pharma Group International) - Amount of Long-Term Liabilities